HEADER TRANSFERASE 18-MAR-16 5IUG TITLE CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE (ALK) IN COMPLEX WITH TITLE 2 5A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1084-1410; COMPND 5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PBAKPAK-8 KEYWDS CATALYTIC DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.H.TU,S.Y.WU REVDAT 3 20-MAR-24 5IUG 1 REMARK REVDAT 2 19-FEB-20 5IUG 1 JRNL REMARK REVDAT 1 18-MAY-16 5IUG 0 JRNL AUTH C.H.TU,W.H.LIN,Y.H.PENG,T.HSU,J.S.WU,C.Y.CHANG,C.T.LU, JRNL AUTH 2 P.C.LYU,C.SHIH,W.T.JIAANG,S.Y.WU JRNL TITL PYRAZOLYLAMINE DERIVATIVES REVEAL THE CONFORMATIONAL JRNL TITL 2 SWITCHING BETWEEN TYPE I AND TYPE II BINDING MODES OF JRNL TITL 3 ANAPLASTIC LYMPHOMA KINASE (ALK). JRNL REF J.MED.CHEM. V. 59 3906 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27031565 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00106 REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.28 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 23183 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1194 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.2831 - 4.0043 0.97 2559 129 0.1868 0.1906 REMARK 3 2 4.0043 - 3.1796 0.99 2493 141 0.1629 0.1832 REMARK 3 3 3.1796 - 2.7780 1.00 2489 132 0.1674 0.2047 REMARK 3 4 2.7780 - 2.5242 1.00 2476 120 0.1704 0.2228 REMARK 3 5 2.5242 - 2.3433 1.00 2434 135 0.1720 0.2165 REMARK 3 6 2.3433 - 2.2052 0.96 2344 131 0.2443 0.3103 REMARK 3 7 2.2052 - 2.0948 1.00 2411 143 0.1761 0.1979 REMARK 3 8 2.0948 - 2.0036 1.00 2439 125 0.2142 0.2439 REMARK 3 9 2.0036 - 1.9265 0.97 2344 138 0.2228 0.2810 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.760 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2334 REMARK 3 ANGLE : 0.929 3169 REMARK 3 CHIRALITY : 0.033 343 REMARK 3 PLANARITY : 0.004 408 REMARK 3 DIHEDRAL : 13.212 874 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5IUG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1000218871. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL44XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23378 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.45500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG2000 MME, 0.1 M TRIS-HCL PH REMARK 280 8.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.95650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.35500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.24750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.35500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.95650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.24750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 1084 REMARK 465 THR A 1085 REMARK 465 SER A 1086 REMARK 465 THR A 1087 REMARK 465 ILE A 1088 REMARK 465 MET A 1089 REMARK 465 THR A 1090 REMARK 465 ASP A 1091 REMARK 465 TYR A 1092 REMARK 465 HIS A 1124 REMARK 465 GLY A 1125 REMARK 465 ALA A 1126 REMARK 465 PHE A 1127 REMARK 465 GLY A 1137 REMARK 465 MET A 1138 REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 PRO A 1142 REMARK 465 SER A 1143 REMARK 465 SER A 1216 REMARK 465 GLN A 1217 REMARK 465 PRO A 1218 REMARK 465 SER A 1219 REMARK 465 ARG A 1275 REMARK 465 ASP A 1276 REMARK 465 ILE A 1277 REMARK 465 TYR A 1278 REMARK 465 ARG A 1279 REMARK 465 ALA A 1280 REMARK 465 SER A 1281 REMARK 465 TYR A 1282 REMARK 465 TYR A 1283 REMARK 465 ARG A 1284 REMARK 465 LYS A 1285 REMARK 465 GLY A 1286 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 465 GLU A 1407 REMARK 465 GLU A 1408 REMARK 465 GLU A 1409 REMARK 465 LYS A 1410 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1101 CG CD CE NZ REMARK 470 ARG A1214 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1642 O HOH A 1758 2.04 REMARK 500 O HOH A 1773 O HOH A 1777 2.07 REMARK 500 O HOH A 1723 O HOH A 1763 2.16 REMARK 500 O HOH A 1745 O HOH A 1747 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1609 O HOH A 1767 3544 2.09 REMARK 500 O HOH A 1763 O HOH A 1766 3644 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1157 -162.96 -103.19 REMARK 500 ARG A1248 -0.87 74.11 REMARK 500 ASP A1249 47.44 -149.73 REMARK 500 ASP A1270 113.54 -160.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1791 DISTANCE = 6.07 ANGSTROMS REMARK 525 HOH A1792 DISTANCE = 7.12 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 729 A 1501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5IUH RELATED DB: PDB REMARK 900 RELATED ID: 5IUI RELATED DB: PDB DBREF 5IUG A 1084 1410 UNP Q9UM73 ALK_HUMAN 1084 1410 SEQADV 5IUG SER A 1097 UNP Q9UM73 CYS 1097 ENGINEERED MUTATION SEQRES 1 A 327 ARG THR SER THR ILE MET THR ASP TYR ASN PRO ASN TYR SEQRES 2 A 327 SER PHE ALA GLY LYS THR SER SER ILE SER ASP LEU LYS SEQRES 3 A 327 GLU VAL PRO ARG LYS ASN ILE THR LEU ILE ARG GLY LEU SEQRES 4 A 327 GLY HIS GLY ALA PHE GLY GLU VAL TYR GLU GLY GLN VAL SEQRES 5 A 327 SER GLY MET PRO ASN ASP PRO SER PRO LEU GLN VAL ALA SEQRES 6 A 327 VAL LYS THR LEU PRO GLU VAL CYS SER GLU GLN ASP GLU SEQRES 7 A 327 LEU ASP PHE LEU MET GLU ALA LEU ILE ILE SER LYS PHE SEQRES 8 A 327 ASN HIS GLN ASN ILE VAL ARG CYS ILE GLY VAL SER LEU SEQRES 9 A 327 GLN SER LEU PRO ARG PHE ILE LEU LEU GLU LEU MET ALA SEQRES 10 A 327 GLY GLY ASP LEU LYS SER PHE LEU ARG GLU THR ARG PRO SEQRES 11 A 327 ARG PRO SER GLN PRO SER SER LEU ALA MET LEU ASP LEU SEQRES 12 A 327 LEU HIS VAL ALA ARG ASP ILE ALA CYS GLY CYS GLN TYR SEQRES 13 A 327 LEU GLU GLU ASN HIS PHE ILE HIS ARG ASP ILE ALA ALA SEQRES 14 A 327 ARG ASN CYS LEU LEU THR CYS PRO GLY PRO GLY ARG VAL SEQRES 15 A 327 ALA LYS ILE GLY ASP PHE GLY MET ALA ARG ASP ILE TYR SEQRES 16 A 327 ARG ALA SER TYR TYR ARG LYS GLY GLY CYS ALA MET LEU SEQRES 17 A 327 PRO VAL LYS TRP MET PRO PRO GLU ALA PHE MET GLU GLY SEQRES 18 A 327 ILE PHE THR SER LYS THR ASP THR TRP SER PHE GLY VAL SEQRES 19 A 327 LEU LEU TRP GLU ILE PHE SER LEU GLY TYR MET PRO TYR SEQRES 20 A 327 PRO SER LYS SER ASN GLN GLU VAL LEU GLU PHE VAL THR SEQRES 21 A 327 SER GLY GLY ARG MET ASP PRO PRO LYS ASN CYS PRO GLY SEQRES 22 A 327 PRO VAL TYR ARG ILE MET THR GLN CYS TRP GLN HIS GLN SEQRES 23 A 327 PRO GLU ASP ARG PRO ASN PHE ALA ILE ILE LEU GLU ARG SEQRES 24 A 327 ILE GLU TYR CYS THR GLN ASP PRO ASP VAL ILE ASN THR SEQRES 25 A 327 ALA LEU PRO ILE GLU TYR GLY PRO LEU VAL GLU GLU GLU SEQRES 26 A 327 GLU LYS HET 729 A1501 42 HETNAM 729 N-[3-(4-{[(5-TERT-BUTYL-1,2-OXAZOL-3-YL) HETNAM 2 729 CARBAMOYL]AMINO}-3-METHYLPHENYL)-1H-PYRAZOL-5-YL]-4- HETNAM 3 729 [(4-METHYLPIPERAZIN-1-YL)METHYL]BENZAMIDE FORMUL 2 729 C31 H38 N8 O3 FORMUL 3 HOH *192(H2 O) HELIX 1 AA1 ASN A 1095 SER A 1103 1 9 HELIX 2 AA2 SER A 1104 LEU A 1108 5 5 HELIX 3 AA3 PRO A 1112 LYS A 1114 5 3 HELIX 4 AA4 SER A 1157 LYS A 1173 1 17 HELIX 5 AA5 LEU A 1204 THR A 1211 1 8 HELIX 6 AA6 ALA A 1222 ASN A 1243 1 22 HELIX 7 AA7 ALA A 1251 ARG A 1253 5 3 HELIX 8 AA8 PRO A 1292 MET A 1296 5 5 HELIX 9 AA9 PRO A 1297 GLY A 1304 1 8 HELIX 10 AB1 THR A 1307 SER A 1324 1 18 HELIX 11 AB2 SER A 1334 SER A 1344 1 11 HELIX 12 AB3 PRO A 1355 TRP A 1366 1 12 HELIX 13 AB4 GLN A 1369 ARG A 1373 5 5 HELIX 14 AB5 ASN A 1375 THR A 1387 1 13 HELIX 15 AB6 ASP A 1389 ASN A 1394 1 6 SHEET 1 AA1 5 ILE A1116 GLY A1123 0 SHEET 2 AA1 5 VAL A1130 VAL A1135 -1 O GLU A1132 N ILE A1119 SHEET 3 AA1 5 LEU A1145 LEU A1152 -1 O VAL A1147 N GLY A1133 SHEET 4 AA1 5 ARG A1192 GLU A1197 -1 O LEU A1196 N ALA A1148 SHEET 5 AA1 5 CYS A1182 SER A1186 -1 N ILE A1183 O LEU A1195 SHEET 1 AA2 3 GLY A1202 ASP A1203 0 SHEET 2 AA2 3 CYS A1255 LEU A1257 -1 O LEU A1257 N GLY A1202 SHEET 3 AA2 3 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 CISPEP 1 LEU A 1190 PRO A 1191 0 -3.44 SITE 1 AC1 20 ALA A1148 GLU A1167 ILE A1171 PHE A1174 SITE 2 AC1 20 ILE A1179 VAL A1180 LEU A1196 GLU A1197 SITE 3 AC1 20 LEU A1198 MET A1199 ALA A1200 GLY A1201 SITE 4 AC1 20 GLY A1202 GLU A1210 HIS A1247 LEU A1256 SITE 5 AC1 20 ILE A1268 GLY A1269 ASP A1270 HOH A1735 CRYST1 51.913 56.495 102.710 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019263 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017701 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009736 0.00000